Manning & Napier Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$3.48M Sell
16,960
-1,075
-6% -$250K 0.03% 225
2017
Q2
$4.38M Buy
18,035
+6,055
+51% +$1.42M 0.04% 198
2017
Q1
$2.86M Buy
11,980
+2,100
+21% +$489K 0.02% 260
2016
Q4
$2.07M Sell
9,880
-630
-6% -$131K 0.01% 274
2016
Q3
$2.42M Buy
+10,510
New +$2.57M 0.01% 247

Other funds holding AGN

Manning & Napier Advisors's AGN Position: Q3 2017 in Review

Manning & Napier Advisors reduced its Allergan plc (AGN) stake by 6% in Q3 2017, selling an estimated $250K and leaving 16,960 shares worth $3.48M. The position accounts for 0.03% of the portfolio, ranked #225.

Manning & Napier Advisors first reported a position in AGN in Q3 2016 and has held it in 5 quarters since. The position peaked at $4.38M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Manning & Napier Advisors held 16,960 shares of Allergan plc worth $3.48M as of Q3 2017.
  • Manning & Napier Advisors sold 1,075 Allergan plc shares in Q3 2017, an estimated $250K.
  • Allergan plc made up 0.03% of Manning & Napier Advisors's portfolio in Q3 2017, its #225 holding.
  • Manning & Napier Advisors first reported a position in Allergan plc in Q3 2016 and has held it in 5 quarters since.
  • Manning & Napier Advisors's Allergan plc position peaked at $4.38M in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.